Click on the first author to read the article's abstract.
Boetes C, Strijk SP, Holland R, Barentsz JO, Van Der Sluis RF, Ruijs JH. False-negative MR imaging of malignant breast tumors. Eur Radiol 1997; 7:1231-4.
Bone B, Pentek Z, Perbeck L, Veress B. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 1997; 38:489-96.
Bone B, Aspelin P, Bronge L, Veress B. Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 1998; 39:279-84.
Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200:639-49.
DeAngelis GA, de Lange EE, Miller LR, Morgan RF. MR imaging of breast implants. Radiographics 1994; 14:783-94.
DiBiase SJ, Komarnicky LT, Schwartz GF, Xie Y, Mansfield CM. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998; 82:2212-20.
Fischer U, Kopka L, Brinck U, Korabiowska M, Schauer A, Grabbe E. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 1997; 7:1002-5.
Friedman EP, Hall-Craggs MA, Mumtaz H, Schneidau A. Breast MR and the appearance of the normal and abnormal nipple. Clin Radiol 1997; 52:854-61.
Gilles R, Guinebretiere JM, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 1993; 188:473-8.
Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging [published erratum appears in Radiology 1994 Oct;193(1):285]. Radiology 1994; 191:625-31.
Gilles R, Guinebretiere JM, Toussaint C, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994; 191:633-8.
Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 1995; 196:415-9.
Gilles R, Meunier M, Lucidarme O, et al. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 1996; 20:9-14.
Graham RA, Homer MJ, Sigler CJ, et al. The efficacy of specimen radiography in evaluating the surgical margins of impalpable breast carcinoma [see comments]. AJR Am J Roentgenol 1994; 162:33-6.
Harms SE, Flamig DP. Staging of breast cancer with MR imaging. Magn Reson Imaging Clin N Am 1994; 2:573-84.
Hochman MG, Orel SG, Powell CM, Schnall MD, Reynolds CA, White LN. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation. Radiology 1997; 204:123-9.
Kacl GM, Liu P, Debatin JF, Garzoli E, Caduff RF, Krestin GP. Detection of breast cancer with conventional mammography and contrast-enhanced MR imaging. Eur Radiol 1998; 8:194-200.
Morris EA, Schwartz LH, Dershaw DD, van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997; 205:437-40.
Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 1997; 169:417-24.
Mussurakis S, Buckley DL, Horsman A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 1997; 203:317-21.
Mussurakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 1997; 70:446-51.
Nunes LW, Schnall MD, Orel SG, et al. Breast MR imaging: interpretation model [see comments]. Radiology 1997; 202:833-41.
Nunes LW, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am J Roentgenol 1997; 169:409-15.
Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190:485-93.
Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy [see comments]. Radiology 1995; 196:115-22.
Orel SG, Hochman MG, Schnall MD, Reynolds C, Sullivan DC. High-resolution MR imaging of the breast: clinical context. Radiographics 1996; 16:1385-401.
Orel SG. High-resolution MR imaging of the breast. Semin Ultrasound CT MR 1996; 17:476-93.
Rieber A, Merkle E, Bohm W, Brambs HJ, Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997; 21:773-9.
Rodenko GN, Harms SE, Pruneda JM, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol 1996; 167:1415-9.
Santyr GE. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast. Magn Reson Imaging Clin N Am 1994; 2:673-90.
Soderstrom CE, Harms SE, Farrell RS, Jr., Pruneda JM, Flamig DP. Detection with MR imaging of residual tumor in the breast soon after surgery. AJR Am J Roentgenol 1997; 168:485-8.
Soo MS, Kornguth PJ, Walsh R, Elenberger CD, Georgiade GS. Complex radial folds versus subtle signs of intracapsular rupture of breast implants: MR findings with surgical correlation. AJR Am J Roentgenol 1996; 166:1421-7.
Soo MS, Kornguth PJ, Walsh R, et al. Intracapsular implant rupture: MR findings of incomplete shell collapse. J Magn Reson Imaging 1997; 7:724-30.
Stelling CB. Breast cancer staging with contrast material-enhanced MR imaging: should it change patient treatment? [editorial; comment]. Radiology 1995; 196:16-8.
Back
to top of page.